Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma.
Krajewska J, Jarzab M, Kukulska A, Czarniecka A, Roskosz J, Puch Z, Wygoda Z, Paliczka-Cieslik E, Kropinska A, Krol A, Handkiewicz-Junak D, Jarzab B. Krajewska J, et al. Among authors: puch z. Nucl Med Mol Imaging. 2019 Oct;53(5):320-327. doi: 10.1007/s13139-019-00608-8. Epub 2019 Sep 5. Nucl Med Mol Imaging. 2019. PMID: 31723361 Free PMC article.
Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.
Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A. Jarzab B, et al. Among authors: puch z. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1077-86. doi: 10.1007/s00259-003-1190-5. Epub 2003 May 29. Eur J Nucl Med Mol Imaging. 2003. PMID: 12783219 Clinical Trial.
[Relapse of differentiated thyroid carcinoma in low-risk patients].
Krajewska J, Czarniecka A, Jarzab M, Kukulska A, Hankiewicz-Junak D, Hasse-Lazar K, Gubała E, Puch Z, Paliczka E, Roskosz J. Krajewska J, et al. Among authors: puch z. Endokrynol Pol. 2006 Jul-Aug;57(4):386-91. Endokrynol Pol. 2006. PMID: 17006841 Polish.
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi.
Kukulska A, Krajewska J, Gawkowska-Suwińska M, Puch Z, Paliczka-Cieslik E, Roskosz J, Handkiewicz-Junak D, Jarzab M, Gubała E, Jarzab B. Kukulska A, et al. Among authors: puch z. Thyroid Res. 2010 Nov 1;3(1):9. doi: 10.1186/1756-6614-3-9. Thyroid Res. 2010. PMID: 21040579 Free PMC article.
Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
Krajewska J, Jarząb M, Czarniecka A, Roskosz J, Kukulska A, Handkiewicz-Junak D, Puch Z, Wygoda Z, Paliczka-Cieślik E, Kropińska A, Gubała E, Jurecka-Lubieniecka B, Jarząb B. Krajewska J, et al. Among authors: puch z. Endokrynol Pol. 2016;67(1):2-11. doi: 10.5603/EP.2016.0001. Endokrynol Pol. 2016. PMID: 26884109 Free article.
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes.
Kukulska A, Krajewska J, Gawkowska M, Paliczka-Cieslik E, Handkiewicz-Junak D, Kropińska A, Puch Z, Olczyk T, Roskosz J, Jarzab B. Kukulska A, et al. Among authors: puch z. Arch Med Sci. 2020 Aug 3;18(5):1241-1247. doi: 10.5114/aoms.2020.97803. eCollection 2022. Arch Med Sci. 2020. PMID: 36160333 Free PMC article.
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study.
Handkiewicz-Junak D, Roskosz J, Hasse-Lazar K, Szpak-Ulczok S, Puch Z, Kukulska A, Olczyk T, Piela A, Paliczka-Cieslik E, Jarzab B. Handkiewicz-Junak D, et al. Among authors: puch z. Thyroid Res. 2009 Aug 1;2(1):8. doi: 10.1186/1756-6614-2-8. Thyroid Res. 2009. PMID: 19646277 Free PMC article.
23 results